We have already shown in patients with VAP [19], bloodstream infections [20] and community-acquired pneumonia [27], that in survivors CRP decreases in the first days of antibiotic therapy while in non-survivors it remains almost unchanged. The gene discussed is CRP; the disease is ventilator-associated pneumonia.